Table 2.
TS neurotransmitter-related candidate genes |
# of tSNPs | # of tSNPs excluded following QCa |
CHR | Neurotransmitter pathway |
Function | Sample size reference study |
Reference |
---|---|---|---|---|---|---|---|
DRD2 | 14 | 11 | Dopamine | Dopamine receptor | 147 TS / 314 controls | [3] | |
HDC | 11 | 15 | Histamine | Histamine synthesis | 520 TS families | [17] | |
MAO-A | 9 | 1 | X | Serotonin (5-HT), dopamine | Degradation of dopamine and 5-HT | 110 TS parent-child trios | [4] |
SLC6A3/DAT1 | 21 | 3 | 5 | Dopamine | Dopamine transporter | 266 Cases / 236 controls | [37] |
TPH2 | 19 | 12 | Serotonin (5-HT) | 5-HT synthesis | 149 TS / 125 controls | [42] | |
| |||||||
Candidate genes implicated in related disorders | |||||||
| |||||||
GABRA2 | 14 | 4 | GABA | GABA receptor | 470 Autism families | [14] | |
SLC1A1 | 52 | 9 | Glutamate | Glutamate transporter | 377 OCD families | [15] | |
| |||||||
Newly investigated candidate gene | |||||||
| |||||||
HRH3 | 8 | 2 | 20 | Histamine | Histamine receptor |
TS, Tourette syndrome; OCD, obsessive-compulsive disorder; ASD, autism spectrum disorder; tSNPs, tagging SNPs; QC, quality check; CHR, chromosome; DRD2, dopamine receptor D2; HDC, l-histidine decarboxylase; MAO-A, monoamine oxidase-A; SLC6A3/DAT1, solute carrier family 6 / dopamine transporter; TPH2, tryptophan hydroxylase 2; GABRA2, GABA-A receptor, alpha 2; SLC1A1, solute carrier family 1 member 1, glutamate transporter; HRH3, histamine receptor H3.